JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.



FIGURE 5. Schematic representation of 2-step bsmAb-based pretargeting strategy. Tumor is pretargeted with antihapten x antitumor F(ab')2 bsmAb. In second step, radiolabeled bivalent hapten is administered. Note bivalent binding of bivalent hapten at tumor cell surface.





Right arrow Return to article

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE